EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations (Q29615392)
Jump to navigation
Jump to search
scientific article (publication date: 6 December 2012)
Language | Label | Description | Also known as |
---|---|---|---|
English | EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations |
scientific article (publication date: 6 December 2012) |
Statements
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations (English)
McCabe MT
Ott HM
Ganji G
Korenchuk S
Thompson C
Van Aller GS
Liu Y
Graves AP
Della Pietra A 3rd
Diaz E
LaFrance LV
Mellinger M
Duquenne C
Tian X
Kruger RG
McHugh CF
Brandt M
Miller WH
Dhanak D
Verma SK
Tummino PJ
Creasy CL
6 December 2012
492
7427
108-12
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference